MDFZF Stock UPDATES Medifocus Inc. (MDFZF) 0.1200 09/13/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medifocus Inc. (MDFZF) 0.1200 $MDFZF

Medifocus, Inc. Announces Financial Results for the Fiscal First Quarter Ending June 30, 2014
Marketwire - Wed Sep 10, 7:45AM CDT
Medifocus Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) (Medifocus or the Company), reported its financial results for the fiscal first quarter ending June 30, 2014 which shows a 32% increase in revenues over the prior year's first quarter.

Medifocus Announces Retraction of Prior Press Release
Marketwire - Mon Sep 08, 6:14PM CDT
Medifocus Inc. (TSX VENTURE: MFS)(OTCQX: MDFZF) (Medifocus) issued a press release earlier today regarding the initiation of research coverage by SeeThruEquity that inadvertently included a target price from the research report. Medifocus hereby retracts this press release.

SeeThruEquity Initiates Research Coverage on Medifocus Inc. With Target Price of $0.52
Marketwire - Mon Sep 08, 7:30AM CDT
Medifocus, Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) announced today that SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, has initiated coverage on Medifocus, Inc. with a target price of $0.52. The report is available at: http://www.seethruequity.com/.

Medifocus, Inc. Announces Financial Results for the Fiscal Year and Fiscal Fourth Quarter Ending March 31, 2014
Marketwire - Wed Jul 30, 8:54AM CDT
Medifocus, Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) (Medifocus or the Company), a revenue generating biotechnology company using focused microwave for the development and commercialization of minimally invasive systems for the treatment of cancerous and benign tumors, today announced its financial results for fiscal year and the fourth fiscal quarter ending March 31, 2014. Sales from its Prolieve(R) Thermodilatation System, reached $5,383,973 for the fiscal year ended March 31, 2014, representing an increase of 198% from the prior year. In July 2012, Medifocus acquired the Prolieve(R) business from Boston Scientific Corporation and recorded revenues of $1,805,969 from Prolieve for the Fiscal Year ended March 31, 2013. The net loss before other charges for the year was $5,222,429, a decrease of $374,043, or 7%, from the previous year primarily due to the revenue growth.

Medifocus, Inc. Is Issued New U.S. Patent Titled, "Apparatus and Method for Pre-Conditioning /Fixation and Treatment of Disease With Heat Activation/Release With Thermoactivated Drugs and Gene Pr
Marketwire Canada - Wed Jul 09, 10:25AM CDT
Medifocus Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) is pleased to announce that on July 1st, 2014, it was issued a new patent by the United States Patent and Trademark Office (USPTO). Medifocus owns an extensive and valuable patent portfolio of over 100 USA and International patents all related to the usage and method of heating technologies to treat diseases almost anywhere within the body.

Medifocus, Inc. Is Issued New U.S. Patent Titled, "Apparatus and Method for Pre-Conditioning /Fixation and Treatment of Disease With Heat Activation/Release With Thermoactivated Drugs and Gene Products"
Marketwire - Wed Jul 09, 10:25AM CDT
Medifocus Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) is pleased to announce that on July 1st, 2014, it was issued a new patent by the United States Patent and Trademark Office (USPTO). Medifocus owns an extensive and valuable patent portfolio of over 100 USA and International patents all related to the usage and method of heating technologies to treat diseases almost anywhere within the body.

Medifocus, Inc. Featured in Article in "BioTuesdays" Titled, "Medifocus Readies Marketing Expansion of Prolieve"
Marketwire Canada - Tue Jul 08, 11:02AM CDT
Medifocus, Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) is pleased to announce that it is featured in today's BioTuesday titled, "Medifocus Readies Market Expansion of Prolieve." Prolieve is a FDA-Approved commercial device for the treatment of symptoms caused by the enlargement of the prostate, which is known as Benign Prostatic Hyperplasia (BPH). The full article can be read on www.biotuesdays.com

Medifocus Inc. Announces Extension of Warrants
Marketwire - Wed Jun 18, 1:29AM CDT
Medifocus Inc. (Medifocus or the Company) (TSX VENTURE: MFS)(OTCQX: MDFZF) is pleased to announce that it has applied to the TSX Venture Exchange (the Exchange) to extend the expiry date of 13,056,997 outstanding common share purchase warrants issued pursuant to the private placement announced November 30, 2012 and to extend the expiry date of 22,196,795 outstanding common share purchase warrants issued pursuant to the private placement announced July 6, 2012 by one year. Both sets of warrants entitle the holder thereof to acquire one common share of Medifocus at a price of $0.20.

Medifocus, Inc. Expands Its Reach Into the Asia-Pacific Market With the Engagement of Euro Japan Marketing Ltd. and Maxim Group, LLC
Marketwire - Mon Mar 17, 7:31AM CDT
Medifocus, Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) (Medifocus or the Company), a leader in the development and commercialization of focused microwave energy to treat cancer and other diseases, is pleased to announce that Medifocus Asia, Ltd. has entered into an advisory agreement with Euro Japan Marketing Ltd. and Maxim Group, LLC to help identify distribution and joint venture partners for the Company's cutting-edge Prolieve(R) Thermodilatation System in Japan and South Korea.

Medifocus, Inc. to Make Clinical Presentation at 24th Annual National Interdisciplinary Breast Center Conference
Marketwire Canada - Wed Mar 12, 8:11AM CDT
Medifocus, Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) is pleased to announce that a clinical poster presentation of the Company's breast cancer treatment system, the Microfocus APA 1000, will be made at the 24th Annual National Interdisciplinary Breast Center Conference, March 15-19, 2014 in Las Vegas, NV.

Medifocus, Inc. Announces $2 Million Second Tranche Closing of $6 Million Convertible Debenture Financing
Marketwire - Tue Mar 11, 7:58AM CDT
Medifocus, Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) announced today the closing of the second tranche of $2 million of its previously announced $6 million convertible debenture financing. The first tranche of $3,540,000 was completed on December 18, 2013.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 20

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 349

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 360

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 79

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 37

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 64

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Phoenix Contact Achieves Guinness Record in Wiring

Updated Category News Views 69

A Blitz of Wires and Innovation Boy, did Phoenix Contact shake things up in Blomberg. On a crisp November day, a group of fresh-faced first-year students pulled off something astounding—wiring 500 terminal blocks in a jaw-dropping 2 minutes and 20 seconds. This wasn’t just any effort; it was enough to earn them a shiny new Guinness World Record. What they did wasn’t...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 192

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 216

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 17

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

Dynacor Group Announces a Significant Dividend Increase for Investors

Updated Category News Views 142

Dynacor Group's Dividend Announcement Montreal-based Dynacor Group Inc. (TSX: DNG) has made headlines with the declaration of an impressive 14.3% increase in its monthly dividend payment for January 2025. This new dividend amount of C$0.01333 per common share, translating into an annual figure of C$0.16, offers a welcome boost to shareholders. The payment will be made on...

Continue Reading
Empowering Education: California Credit Union Teacher Grants

Updated Category News Views 84

California Credit Union Foundation Supports Educators The California Credit Union Foundation is thrilled to announce its recent initiative to enhance educational experiences through innovative projects. With its Fall 2024 Teacher Grant Program, the foundation is investing in the creativity of teachers by providing individual grants of $500 each for a total of 10 grants....

Continue Reading
What to Expect from Agios Pharmaceuticals' Upcoming Earnings

Updated Category News Views 143

What to Expect from Agios Pharmaceuticals' Upcoming Earnings Agios Pharmaceuticals (NASDAQ: AGIO) is gearing up to unveil its quarterly earnings report soon. Investors are eagerly awaiting this announcement, looking for key insights that could shape their investment strategy. Analysts project Agios to report earnings per share (EPS) of $-1.01. This figure sets the stage...

Continue Reading
US Capital Global Strengthens European Operations with New Leaders

Updated Category News Views 117

Exciting Developments at US Capital Global US Capital Global is making waves by expanding its London office, showcasing its commitment to growth and excellence in the financial services sector. Recently, the firm announced the addition of three highly experienced bankers to its team: Michael Silberberg, Mark Olson, and James Bowles. These new appointments are expected to...

Continue Reading
Victors Home Solutions Expands to Serve Cincinnati Residents

Updated Category News Views 109

Victors Home Solutions Is Now Serving Cincinnati Good news for Cincinnati homeowners: Victors Home Solutions is bringing its award-winning roofing services to your neighborhood. Trusted for its craftsmanship and straightforward service, the company is expanding into the Cincinnati area with the same focus on quality workmanship that folks across the Midwest have come to...

Continue Reading